The estrogen receptor was overall positive in 27.6% of cases and 16.2% of controls, of which 27.6% of cases and 13.2% of controls were above the cut-point of ≥1% positive meningioma cells (p = 0.14). This evidence concerns the gene ESR1 and meningioma.